Unfortunately, serum biomarkers are not early hallmarks of PC, but combining at least three of them, such as CA19-9, OPN, and MUC4, with MRI will identify a subset of patients that should undergo EUS. This evidence concerns the gene MUC4 and pachyonychia congenita.